ESR1 and Alzheimer disease: Lambert et al. (2004[28]) found that -219 G/T promoter polymorphism influenced binding to the estrogen receptor and altered transcriptional activity in response to estrogen, possibly being involved in increased risk for AD in women bearing an ε4 allele.